Authors:
Aseni, P
Vertemati, M
Minola, E
Arcieri, K
Bonacina, E
Camozzi, M
Osio, C
Forti, D
Citation: P. Aseni et al., Kaposi's sarcoma in liver transplant recipients: Morphological and clinical description, LIVER TRANS, 7(9), 2001, pp. 816-823
Authors:
Alberti, AB
Belli, LS
Airoldi, A
de Carlis, L
Rondinara, G
Minola, E
Vangeli, M
Cernuschi, A
D'Amico, M
Forti, D
Pinzello, G
Citation: Ab. Alberti et al., Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study, LIVER TRANS, 7(10), 2001, pp. 870-876
Authors:
De Carlis, L
Giacomoni, A
Slim, AO
Pirotta, V
Di Benedetto, F
Manoochehri, F
Lauterio, A
Sammartino, C
Rondinara, GF
Forti, D
Citation: L. De Carlis et al., Factors involved in the functional recovery of a liver graft with particular emphasis on liver steatosis: A multivariate analysis, TRANSPLAN P, 33(5), 2001, pp. 2720-2722
Authors:
Chahin, NJ
De Carlis, L
Slim, AO
Rossi, A
Groeso, CA
Rondinara, GF
Garnbitta, P
Zanan, G
Forti, D
Citation: Nj. Chahin et al., Long-term efficacy of endoscopic stenting in patients with stricture of the biliary anastomosis after orthotopic liver transplantation, TRANSPLAN P, 33(5), 2001, pp. 2738-2740
Authors:
Salizzoni, M
Cavallari, A
Risaliti, A
Filipponi, F
Gerunda, GE
Forti, D
Fassati, LR
Cillo, U
Castagneto, M
Valente, U
Tisone, G
Citation: M. Salizzoni et al., Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation, TRANSPLAN P, 33(3), 2001, pp. 2258-2262
Authors:
Belli, LS
Alberti, AB
Rondinara, GF
de Carlis, L
Corti, A
Mazza, E
Airoldi, A
Cernuschi, A
de Gasperi, A
Forti, D
Pinzello, GB
Citation: Ls. Belli et al., Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: Interim report of a prospective randomized trial, TRANSPLAN P, 33(1-2), 2001, pp. 1353-1354
Authors:
Candolfi, M
Bigler, F
Campbell, P
Heimbach, U
Schmuck, R
Angeli, G
Bakker, F
Brown, K
Carli, G
Dinter, A
Forti, D
Forster, R
Gathmann, A
Hassan, S
Mead-Briggs, M
Melandri, M
Neumann, P
Pasqualini, E
Powell, W
Reboulet, JN
Romijn, K
Sechser, B
Thieme, T
Ufer, A
Vergnet, C
Vogt, H
Citation: M. Candolfi et al., Principles for regulatory testing and interpretation of semi-field and field studies with non-target arthropods, ANZ SCHAD-J, 73(6), 2000, pp. 141-147
Authors:
Frisinghelli, C
Delaiti, L
Grando, MS
Forti, D
Vindimian, ME
Citation: C. Frisinghelli et al., Cacopsylla costalis (Flor 1861), as a vector of apple proliferation in Trentino, J PHYTOPATH, 148(7-8), 2000, pp. 425-431
Authors:
Belli, LS
Zavaglia, C
Alberti, AB
Poli, F
Rondinara, G
Silini, E
Taioli, E
de Carlis, L
Scalamogna, M
Forti, D
Pinzello, G
Ideo, G
Citation: Ls. Belli et al., Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation, HEPATOLOGY, 31(6), 2000, pp. 1345-1350
Authors:
De Carlis, L
Belli, LS
Colella, G
Rondinara, GF
Slim, AO
Alberti, A
Aseni, P
Sansalone, CV
Pirotta, V
Di Benedetto, F
Forti, D
Citation: L. De Carlis et al., Serum lipid changes in liver transplantation: Effect of steroids withdrawnin a prospective randomized trial under cyclosporine A therapy, TRANSPLAN P, 31(1-2), 1999, pp. 391-393
Authors:
Belli, LS
Zavaglia, C
Alberti, AB
Rondinara, GF
De Carlis, L
Silini, E
Poli, F
Scalamogna, M
Tinelli, G
Forti, D
Ideo, G
Citation: Ls. Belli et al., Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 483-484
Authors:
Andreone, P
Caraceni, P
Grazi, GL
Belli, L
Milandri, GL
Ercolani, G
Jovine, E
D'Errico, A
Dal Monte, PR
Ideo, G
Forti, D
Mazziotti, A
Cavallari, A
Bernardi, M
Citation: P. Andreone et al., Lamivudine treatment for acute hepatitis B after liver transplantation, J HEPATOL, 29(6), 1998, pp. 985-989